High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years

✍ Scribed by Martha Arellano; Elliott Winton; Lin Pan; Lisa Lima; Mourad Tighiouart; Kapil Bhalla; Leonard T. Heffner; Jessica Neely; Donald Hutcherson; Morgan McLemore; Amelia Langston; H. Jean Khoury

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 136 KB
• Volume: 118
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/cncr.26290